Importantly, several key ferroptosis drivers and suppressors, including MAPK1, TLR4, ATM, ULK2, NFS1, and HMOX1, have been identified, offering potential therapeutic targets to modulate cancer cell susceptibility to ferroptosis. This evidence concerns the gene MAPK1 and cancer.